scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.MRGENTOX.2010.06.002 |
P698 | PubMed publication ID | 20561600 |
P2093 | author name string | Vera Bianchi | |
Giovanna Pontarin | |||
Paola Ferraro | |||
Chiara Rampazzo | |||
Peter Reichard | |||
Elisa Franzolin | |||
Miriam Frangini | |||
Cristina Miazzi | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2-10 | |
P577 | publication date | 2010-06-16 | |
P1433 | published in | Mutation Research | Q6943732 |
P1476 | title | Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances | |
P478 | volume | 703 |
Q36553774 | A continuous spectrophotometric enzyme-coupled assay for deoxynucleoside triphosphate triphosphohydrolases |
Q48252877 | A defective dNTP pool hinders DNA replication in cell cycle-reactivated terminally differentiated muscle cells |
Q41813473 | A mathematical model of human thymidine kinase 2 activity. |
Q92223851 | Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice |
Q42218789 | Allosteric regulation of the human and mouse deoxyribonucleotide triphosphohydrolase sterile α-motif/histidine-aspartate domain-containing protein 1 (SAMHD1). |
Q27316931 | Crystal structures of the novel cytosolic 5'-nucleotidase IIIB explain its preference for m7GMP |
Q97643915 | Defects in mtDNA replication challenge nuclear genome stability through nucleotide depletion and provide a unifying mechanism for mouse progerias |
Q41997479 | Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase |
Q38572102 | Deoxyribonucleotide metabolism, mutagenesis and cancer |
Q38220118 | Deoxyribonucleotides as genetic and metabolic regulators |
Q47843426 | Fast and sensitive HPLC-MS/MS method for direct quantification of intracellular deoxyribonucleoside triphosphates from tissue and cells |
Q33606917 | GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state |
Q34558619 | Gene expression deregulation in postnatal skeletal muscle of TK2 deficient mice reveals a lower pool of proliferating myogenic progenitor cells |
Q24605899 | How SAMHD1 changes our view of viral restriction |
Q38011246 | Human HAD phosphatases: structure, mechanism, and roles in health and disease |
Q90632452 | Identification of a novel heterozygous guanosine monophosphate reductase (GMPR) variant in a patient with a late-onset disorder of mitochondrial DNA maintenance |
Q58086605 | Identification of inhibitors of the dNTP triphosphohydrolase SAMHD1 using a novel and direct high throughput assay |
Q37149212 | Inhibition of DNA synthesis facilitates expansion of low-complexity repeats: is strand slippage stimulated by transient local depletion of specific dNTPs? |
Q36690563 | Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply |
Q28477625 | Limited dCTP availability accounts for mitochondrial DNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) |
Q36170870 | Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells |
Q39632964 | Mechanism of the allosteric regulation of Streptococcus mutans 2'-deoxycytidylate deaminase. |
Q27001150 | Mitochondrial DNA damage and its consequences for mitochondrial gene expression |
Q36728526 | Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response |
Q28081515 | Nucleotide salvage deficiencies, DNA damage and neurodegeneration |
Q34399422 | Onset and organ specificity of Tk2 deficiency depends on Tk1 down-regulation and transcriptional compensation |
Q42414226 | Out of S-phase: shift of subunits for ribonucleotide reduction |
Q47547801 | Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria |
Q57061841 | Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy |
Q90231049 | Purine-Metabolising Enzymes and Apoptosis in Cancer |
Q26785350 | Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications |
Q37404941 | Relationships between human vitality and mitochondrial respiratory parameters, reactive oxygen species production and dNTP levels in peripheral blood mononuclear cells. |
Q35758944 | Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue |
Q55056626 | Restricting HIV the SAMHD1 way: through nucleotide starvation. |
Q38218536 | Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies |
Q36812510 | Ribonucleotide reductase association with mammalian liver mitochondria |
Q34401495 | Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice |
Q52431678 | SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation. |
Q34399058 | SAMHD1 prevents autoimmunity by maintaining genome stability |
Q34058270 | SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors |
Q52723862 | SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity. |
Q38728094 | Stably transfected adherent cancer cell models with decreased expression of 5'-nucleotidase cN-II. |
Q34383850 | Structural basis of cellular dNTP regulation by SAMHD1. |
Q44518086 | Substrate ambiguity among the nudix hydrolases: biologically significant, evolutionary remnant, or both? |
Q34548496 | Substrates and Inhibitors of SAMHD1. |
Q41014443 | The Deoxynucleoside Triphosphate Triphosphohydrolase Activity of SAMHD1 Protein Contributes to the Mitochondrial DNA Depletion Associated with Genetic Deficiency of Deoxyguanosine Kinase |
Q47118199 | The Dynamic Interplay between HIV-1, SAMHD1, and the Innate Antiviral Response |
Q28771774 | The NTP pyrophosphatase DCTPP1 contributes to the homoeostasis and cleansing of the dNTP pool in human cells |
Q37143515 | The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. |
Q47284445 | The expression profile of sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1) in feline tissues |
Q30368734 | The first crystal structure of a dTTP-bound deoxycytidylate deaminase validates and details the allosteric-inhibitor binding site. |
Q91808380 | The missing link: allostery and catalysis in the anti-viral protein SAMHD1 |
Q28570313 | Thymidine kinase 1 regulatory fine-tuning through tetramer formation |
Q59349536 | Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus |
Q53695910 | dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence. |
Q34169187 | dNTP pool modulation dynamics by SAMHD1 protein in monocyte-derived macrophages. |
Q41933397 | p21 Restricts HIV-1 in Monocyte-Derived Dendritic Cells through the Reduction of Deoxynucleoside Triphosphate Biosynthesis and Regulation of SAMHD1 Antiviral Activity |
Q37240650 | p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway |
Search more.